↓ Skip to main content

Autoantibodies to Ezrin are an early sign of pancreatic cancer in humans and in genetically engineered mouse models

Overview of attention for article published in Journal of Hematology & Oncology, September 2013
Altmetric Badge

Citations

dimensions_citation
42 Dimensions

Readers on

mendeley
40 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Autoantibodies to Ezrin are an early sign of pancreatic cancer in humans and in genetically engineered mouse models
Published in
Journal of Hematology & Oncology, September 2013
DOI 10.1186/1756-8722-6-67
Pubmed ID
Authors

Michela Capello, Paola Cappello, Federica Caterina Linty, Roberto Chiarle, Isabella Sperduti, Anna Novarino, Paola Salacone, Giorgia Mandili, Alessio Naccarati, Carlotta Sacerdote, Stefania Beghelli, Samantha Bersani, Stefano Barbi, Claudio Bassi, Aldo Scarpa, Paola Nisticò, Mirella Giovarelli, Paolo Vineis, Michele Milella, Francesco Novelli

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 40 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 3%
Unknown 39 98%

Demographic breakdown

Readers by professional status Count As %
Researcher 10 25%
Student > Ph. D. Student 8 20%
Student > Bachelor 4 10%
Other 3 8%
Professor > Associate Professor 3 8%
Other 5 13%
Unknown 7 18%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 10 25%
Medicine and Dentistry 8 20%
Agricultural and Biological Sciences 3 8%
Pharmacology, Toxicology and Pharmaceutical Science 1 3%
Nursing and Health Professions 1 3%
Other 5 13%
Unknown 12 30%